已发表论文

合并腹腔感染重症患者的抗菌和微生物学特征:来自贝斯以色列女执事医疗中心的观察数据

 

Authors Tong Y, Li Q, Liu S, Liu T, Qu K, Liu C, Zhang J 

Received 22 December 2021

Accepted for publication 10 February 2022

Published 25 February 2022 Volume 2022:15 Pages 2127—2136

DOI https://doi.org/10.2147/IJGM.S354258

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser

Purpose: We describe the clinical characteristics, isolated microorganisms and antibiotics used in patients with cIAIs during ICU stay.
Methods: A retrospective analysis of data from Beth Israel Deaconess Medical Center was performed.
Results: A total of 316 patients with cIAIs were included, 57.0% of them were male and the median age was 63 years. A total of 239 patients did have cultures taken, and 74 patients had a positive microbial result. The main pathogens were Escherichia coli , Staphylococci (coagulase negative), Enterococcus sp . and Bacteroides fragilis . The main antibiotics given were vancomycin, metronidazole, piperacillin tazobactam and ciprofloxacin. Univariable and multivariable Cox regression analyses showed that receiving more antibiotics reduced ICU mortality, but the same results were not obtained in the analysis of hospital mortality.
Conclusion: The main Gram-positive microorganisms for empirical antimicrobial therapy were Staphylococci (coagulase negative), Enterococcus sp . and Staphylococcus aureus , and Gram-negative microorganisms were Escherichia coli Bacteroides fragilis and Klebsiella pneumoniae . The use of more antibiotics reduced ICU mortality, but the same results were not obtained in the analysis of hospital mortality.
Keywords: intra-abdominal infection, culture, microorganism, antibiotics, intensive care unit, mortality